Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients
Objective: To investigate the efficacy of the dopamine agonist cabergoline in uncontrolled acromegaly despite long-acting somatostatin analog (SSA). Methods: Thirty-five patients with acromegaly who were followed up in the department of endocrinology and metabolism of our university were analyzed....
Saved in:
| Main Authors: | Mehmet Muhittin Yalçın, Gizem Bedir Keser, Meriç Coşkun, Afruz Babayeva, Emrah Çeltikçi, Mehmet Arda İnan, Emetullah Cindil, Aylar Poyraz, Ethem Turgay Cerit, Alev Eroğlu Altınova, Müjde Aktürk, Füsun Baloş Törüner, Mehmet Ayhan Karakoç, İlhan Yetkin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2024-10-01
|
| Series: | Gazi Medical Journal |
| Subjects: | |
| Online Access: | https://gazimedj.com/articles/long-term-results-of-cabergoline-add-on-long-acting-somatostatin-analogue-therapy-in-acromegaly-patients/doi/gmj.2024.4281 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperprolactinemia in children and adolescents and longterm follow-up results of prolactinoma cases: a single-centre experience
by: Tuğba Kontbay, et al.
Published: (2022-10-01) -
Comparative study of cabergoline and hydroxychloroquine to prevent ovarian hyperstimulation syndrome (OHSS) in PCOS patients: a pilot randomized clinical trial
by: Elnaz Salari, et al.
Published: (2025-05-01) -
Depression and Anxiety States of Patients Followed in Pituitary Polyclinic
by: Afruz Babayeva, et al.
Published: (2024-01-01) -
Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas
by: Edward Mignone, et al.
Published: (2025-01-01) -
Response to Treatment in a sample of Iraqi Patients with Prolactinoma
by: Rana Kareem Mohammed, et al.
Published: (2025-04-01)